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MEDICAL GENETICS IN PRACTICE
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Background: Congenital anomaly registers collect data on antenatally and postnatally detected anomalies
for surveillance, research, and public health purposes. Each anomaly is coded using the International
Statistical Classification of Diseases and Related Health Problems (ICD-9/ICD-10) based on body systems,
allowing accurate comparisons between registers for individual anomalies. When commencing an
environmental, epidemiological study, it became clear to us that there is no standard classification that
takes aetiology into account. This paper describes a new classification for use in studies addressing
aetiology.
Method: A classification system was evolved and piloted using cases in a study of geographical variation
in congenital anomaly prevalence.1 Cases that were difficult to categorise were noted, and after discussion
with a team of experts, the classification was adjusted accordingly.
Results and conclusion: A robust, hierarchical method of classifying birth defects into eight categories has
been produced, for use at source of data registration in conjunction with, but independent of, ICD coding.
S
ignificant progress has been made into understanding
the aetiology of birth defects over the past 20 years. The
detection of chromosome microdeletions has explained
the aetiology of some non-Mendelian syndromes and the
identification of single gene mutations has shown or
confirmed the Mendelian basis for others. However, in spite
of advances in new genomic technology, many birth defects
have unknown aetiology and there is concern about
environmental causes.
Epidemiological studies looking into the causes of birth
defects have not always taken different aetiologies into
account, clumping together all cases of a specific defect for
analysis. For example, diaphragmatic hernia could be an
isolated anomaly or associated with a chromosome error such
as trisomy 18 or might be part of the autosomal recessive
Fryns’ syndrome. To derive a valid conclusion from such a
study it is necessary to ensure that aetiology has been taken
into account.
Population based birth defect registries are a valuable
resource for studies of environmental and genetic aetiology.
ICD-102 has become established as the international coding
system of choice for individual specific anomalies,3 and is
used by most registers for this purpose.
Classification of cases into anomaly subgroups is more
difficult and is dependent upon the intended use of the data.
Surgeons have classically used a morphological approach,
whilst geneticists prefer a system based on inheritance, as in
McKusick’s Mendelian Inheritance in Man,4 which provides a
number for every described single gene disorder, using an
inheritance based tree structure. For dysmorphologists,
Jones5 proposed a system reclassifying all birth defects into
malformations, deformations, and disruptions, incorporating
aetiological links that are sometimes speculative. None of
these, however, fulfils the requirements for epidemiological
research requiring grouping by aetiology.
For epidemiological studies it is necessary to classify
defects according to presumed aetiological commonality,
allowing further investigation of those cases where an, as
yet unknown, environmental element could be important.
In 2000, commencing an investigation into the patterns of
geographic variation in congenital anomaly rates across five
geographical areas of Britain, it became clear that a robust
system of classification was necessary.
The aim of this paper is to describe a system for the
classification of birth defects by aetiology for epidemiological
research, to be used by congenital anomaly registers at the
time of case registration. Classification would thus take into
account information available at the time of registration,
which may include family history, and diagnostic and
laboratory test data in addition to the anomalies.
The basic requirements for such a system include: (a) ease
of use by people of different scientific backgrounds; (b) all
anomalies covered—that is, no miscellaneous group; and (c)
a method of categorising those with no specific diagnosis.
METHODS
The study population comprised 845 000 births to mothers
resident in five geographically defined areas of the UK that
have congenital anomaly registers, covering the period 1991–
1999. Well defined, significant anomalies were included. In
all, 10 844 cases were analysed.
A hierarchical system of classification was drafted in which
cases could be classified to one category only, the highest in
the list of categories applicable. This was piloted (by DW and
PB) to categorise the 10 844 cases in the geographical
heterogeneity study.1 Thus, it was possible to highlight areas
for adjustment, draw attention to the cases that were difficult
to classify, and test the overall robustness of the classification
system. Some modifications were then applied. For further
validation of the groups, the proposed system was presented
at the 2002 British Isles Network of Congenital Anomaly
Registers (BINOCAR) meeting for those actively involved
with running or managing congenital anomaly registers, and
at the Tenth Manchester Birth Defects meeting, attended by
clinical geneticists, for further consideration, with particular
emphasis on the aetiology of specific defects. In addition, a
list of ‘‘difficult to categorise’’ cases was offered to a panel of
experienced geneticists for their opinion. A consensus was
Abbreviations: BINOCAR, British Isles Network of Congenital Anomaly
Registers; C, chromosome; F, familial; I, isolated; M, multiple; MD,
microdeletion; ND, new dominant; S, syndrome; T, teratogen
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reached, and these results have been incorporated into the
guidance lists, which have been provided for many categories
to improve consistency.
RESULTS
Table 1 gives the final classification categories. The flow chart
illustrates the route through the hierarchical system. Table 2
lists the diagnoses to be included in the microdeletion (MD)
category; table 3 the list of teratogens (T), and table 4 the
new dominant (ND) mutations.
Analysis
In order to use this classification system for epidemiological
studies of potential environmental influence we recommend:
(a) those cases in the teratogen and familial categories are
excluded as of known aetiology; (b) the chromosome,
microdeletion, new dominant mutation, and syndrome
subgroups are mutually exclusive categories, separately
analysed without reference to individual component anoma-
lies. an example here would be a heart defect in Down’s
syndrome which would only be analysed in the chromosome
group; and (c) malformations in the multiple category are
counted in each of the different anomaly subgroups
represented, as well as in a combined ‘‘M’’ category.
Although designed with environmental epidemiology in
mind, these categories may also be used for wider ranging
studies such as new dominant mutation rates, where
consistent categorisation will allow accurate comparisons
between registers and regions.
DISCUSSION
In order to make progress in identifying new aetiological
factors, epidemiological research needs to take into account
new knowledge in clinical genetics. Without careful attention
to classification based on knowledge of the causes of birth
defects, epidemiological studies may fail to identify environ-
mental teratogens because of the inclusion of cases with
the same defect but different aetiologies. We have tested
this classification system in a study of geographical and
sociodemographical variation in the rates of congenital
anomalies.1
Although it is possible to categorise defects appropriately
for a specific research study, it is more accurate and less time
consuming to do so at source when entering and coding each
anomaly, using locally available information such as family
Table 1 Categories for the classification of birth defects
in hierarchical order
C: Chromosome For microscopically visible, unbalanced
chromosome abnormalities.
MD*: Microdeletion For all submicroscopic chromosome
abnormalities including
microdeletions, uniparental disomy
and imprinting mutations.
T*: Teratogen For known teratogens and prenatal infections.
ND*: New dominant For new dominant mutations.
F: Familial For familial disorders not included as a
new dominant.
S: Syndrome For recognised non-familial, non-
chromosomal syndromes.
I: Isolated For isolated anomalies.
M: Multiple For multiple anomalies and
associations.
*List provided. C: includes trisomies (+ mosaics), triploidy, visible
deletions such as 4p (Wolf-Hirschorn), duplications, insertions, and
unbalanced translocations. Microdeletions in category ‘‘MD’’ are
excluded. MD: all submicroscopic chromosome abnormalities. These
disorders may be reported to a register in different ways depending on
the source of the data, thus any chromosome error or syndrome name
mentioned in table 2 should be coded MD. T: cases with a good history of
teratogen ingestion, or a specified infection, as well as anomalies strongly
consistent with the exposure (table 3). ND: autosomal dominant
conditions where the new mutation rate is >90% and the diagnosis easy
to make at birth, as detailed in table 4. If there is known to be a family
history of the condition it should be coded as ‘‘F’’ but ‘‘ND’’ is the default
category for these conditions. F: all non-chromosomal, familial conditions
not included in ‘‘ND’’, such as tuberous sclerosis, Meckel-Gruber
syndrome, autosomal recessive polycystic kidney disease, fragile X
syndrome. S: all non-chromosomal, non-Mendelian syndromes not
included in one of the previous categories, such as Kabuki syndrome. I:
all isolated anomalies not included in one of the above categories.
Included here are (a) single anomalies such as gastroschisis, talipes, or
cleft lip; (b) more than one anomaly from the same system such as a VSD
and coarctation, or polydactyly of hands and feet; and (c) more than one
anomaly as part of a sequence such as spina bifida with talipes or
hydrocephalus, lung hypoplasia and renal agenesis. M: all that remain
should be multiple, unrelated anomalies from more than one system with
no unifying diagnosis and recognised associations that are not regarded
as a syndrome (for example, VATER, CHARGE, MURCS).
Table 2 Diagnoses to be coded MD
Chromosomal/genetic error Syndrome names
22q11 deletion Di George, velocardiofacial or
Schprintzen syndrome
15q11 deletion, maternal or paternal
disomy, imprinting mutations
Prader-Willi or Angelman
syndrome
7q11 deletion, elastin mutation Williams syndrome
11p13 deletion, PAX 6 or WT1
mutation
WAGR, Aniridia-Wilms’
tumour
11p15 duplication, paternal
isodisomy, imprinting mutations
Beckwith-Wiedemann
syndrome
20p12 deletion or JAG1 mutation Alagille syndrome
17p11 deletion Smith-Magenis syndrome
5q35 deletion, NSD1 mutation Sotos syndrome
Table 3 Teratogens and prenatal infections
included in ‘‘T’’ and where observed defects are
strongly associated with the teratogen
Drugs
Abortifacients
ACE inhibitors
Alcohol
Anti-epileptics
Cocaine and other illicit drugs
Cytotoxics
Diabetes, poorly controlled
Folic acid inhibitors
Lithium
Severe maternal illness
Thalidomide
Vitamin A analogues
Warfarin
Infections
Cytomegalovirus
Herpes simplex
Parvovirus
Rubella
Toxoplasmosis
Varicella
Table 4 New dominant mutations included in
‘‘ND’’
Achondroplasia
Apert’s syndrome
Thanatophoric dysplasia
Campomelic dysplasia
Osteogenesis imperfecta types II* or III
*Type IIc is recessive and ideally should not be included here
but if the type of OI II is not known, it should be included in
this category.
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history and test results. A classification system needs to be
simple to use by all those involved in registering anomalies,
to be consistent and reproducible. It also needs to be
appropriate for the circumstances. There is no doubt that a
more detailed system using case specific genetic information
would be more accurate, but this would not be operable by
local congenital anomaly registers. If future research is to be
immediately comparable, the same system must be usable by
all.
Microdeletions
The categorisation of syndromes now known to be due to a
chromosome microdeletion, uniparental disomy or an
imprinting mutation was widely discussed during the pilot
phase. The main priority was to keep all cases with the same
diagnosis in the same category. The option of categorisation
under ‘‘syndrome’’ was considered, but some concerns were
raised. If the source of a case is the cytogenetic laboratory, the
diagnosis will be given as, for instance, 22q11 deletion and
hence coded C. A similar case from the cardiologist might be
reported as Di George or velocardiofacial syndrome and coded
S. Conditions such as Prader-Willi syndrome may be due to a
paternal microdeletion, maternal isodisomy, or an imprinting
mutation. Some will be reported as 15q11 deletion by the
laboratory and others as Prader-Willi syndrome, with no
mention of the underlying mechanism. Other diagnoses such
as Alagille syndrome may have a chromosome deletion, a
positive family history or neither and thus could be coded as
C or F or S.
Recent research has suggested that imprinting mutations
may be more common following assisted reproduction,12–14
involving mechanisms of which we currently have little
knowledge. Further similar research questions are inevitable.
It is therefore important to be able to retrieve such cases with
ease. For these reasons, a separate category, MD, has been
created for all of these cases. A disadvantage of this category
from a purely genetic perspective is that it pools basic genetic
mechanisms (imprinting, uniparental disomy, and chromo-
some microdeletions) that probably do not have the same
underlying aetiology. A compromise had to be reached so that
cases with the same diagnosis, but reported in different ways
(for example, di George syndrome as: 22q11 deletion, or di
George, Schprintzen, or velocardiofacial syndromes) were not
lost, and to provide for the fact that, in many cases, the basic
genetic error will not be known by the register. The MD
category keeps all these cases together for potential future
research and offers clear guidance as to their coding. Finer
subdivisions can later be made depending on the specific
research question. A list of conditions to be included in this
category is provided (table 2), to be updated annually, taking
into account new knowledge that may move a condition from
one category to another, for example, from S to MD. In
theory, these cases could also be classified under C but it
would not be possible, or desirable, to produce an inclusion
list for all chromosomal errors. As a list seemed the only way
to ensure inclusion of all like cases, a specific category was
provided.
Teratogens
This is often a difficult category for diagnosticians. For the
purposes of this classification system, in situations where, for
environmental epidemiological studies, cases are excluded
from further analysis if aetiology is known, only those cases
where the diagnosis is clear should be categorised as T.
Where there is uncertainty, M or I would be preferable.
New dominants
One of the most controversial categories is ND, for new
dominant mutations. These cases are small in number but of
importance, and have been promoted for decades as the
monitor of mutation rates in populations.6–8
For this category, consistency was deemed of the greatest
importance. Some registers have access to good family history
data and this would allow accurate classification of cases
such as tuberous scerosis or Noonan’s syndrome (between F
and ND); other registers have poorer access. In the absence of
such data, allocation is likely to vary between registers. It was
therefore decided to use this category in a limited way
accepting only conditions that are usually (>90%) new
mutations, reliably diagnosable at birth. A known family
history would supersede these assumptions, but in the
absence of this information, a new mutation would be
assumed. This category will allow an easy comparison of the
new mutation rate between registers.
Recent research has shown that new mutations in Apert’s
syndrome, achondroplasia, and (probably) thanatophoric
dysplasia are exclusively paternal, and related to paternal
age.9–11 This does not invalidate the value of new dominant
mutations as a measure of pro-mutagenic processes, but
suggests it would primarily assess paternal new mutations
and that paternal age should be taken into account when
making population comparisons.
Syndrome
One of the more common problems identified, by discussion,
at the BINOCAR conference is loose usage of the word
‘‘syndrome’’. This term brings together many conditions with
very diverse aetiologies, such as Down’s syndrome, Di George
syndrome, Smith-Lemli-Opitz syndrome, and Kabuki syn-
drome. The value of the hierarchical system is that it allows
each of these to be categorised correctly before the offer of
category S.
The lists provided for specific categories err on the side of
caution. Assumptions have been made that some registers
will have difficulty obtaining information about family
history (relevant to new dominant cases in particular),
association diagnoses (currently included within the M
group) and other issues. If this proves not to be the case,
the ND category, for example, could be extended to include
conditions such as tuberous sclerosis, and Pfeiffer, Crouzon,
or Noonan’s syndromes. Several registers within the UK
BINOCAR network have agreed to pilot this system at source
with a planned annual review. After this first annual
appraisal by the authors, the BINOCAR coding group will
meet annually to review the categories in the light of new
diagnoses or tests. Problem cases can be submitted to this
group and changes made as necessary at this time. Thus,
consistency will be maintained.
Rassmussen et al15 recently published a classification
system for the US National Birth Defects Prevention Study.
It is specific to the cases included in that study for use by
medical geneticists when classifying cases, but its basis is
very similar to that described here. A hierarchical system
with chromosome, genetic, teratogen, syndrome, isolated,
and multiple categories is reported. The similarity between
these two independently derived systems would seem to add
weight to our proposed classification. We also extend the
system for use prospectively at the point of data entry in
registers.
We accept that this proposed classification is not perfect
and has required compromise, but believe it to be signifi-
cantly better than using ICD codes alone.
As a work in progress, there will be the opportunity for
continual improvement.
In summary, an aetiological classification of birth defects
has been developed for use by registers at the point of data
entry. We believe this to be a simple, robust and reproducible
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system for use in future epidemiological and aetiological
research.
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APPENDIX 1
PILOT STUDY
There are currently two analytical approaches available to
environmental epidemiological researchers. The most basic,
used by many studies in the past, groups all cases of a
particular anomaly together. Hence the 304 cases of
exomphalos would have been analysed as one group instead
of: 79 C, 1 ND, 1 F, 16 S, 132 I, and 75 M if the proposed
classification was used. Using I as the default category, 57%
would be re-classified.
For cleft palate, comparing our classification with a single
group analysis would result in a 34% re-classification as
follows: 56 C, 8 MD, 2 T, 1 ND, 9 F, 19 S, 311 I, and 6 M.
More recently, some researchers have used ICD codes to
separate out cases with a chromosome aetiology and cases
with isolated versus multiple anomalies. Figs 1 and 2
compare this method of categorisation with the proposed
classification. Comparing these approaches resulted in re-
classification in 16% of the exomphalos cases and 21% of
those with a cleft palate.
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Proposed classificationICD codes
1 = MD
78 = C
C = 79
102 = II = 102
1 = F
11 = S
2 = I
10 = M
S = 24
1 = C
5 = S
28 = I
65 = M
M = 99
Figure 1 The categorisation of exomphalos using the proposed
classification system compared with ICD codes.
Proposed classificationICD codes
56 = CC = 56
247 = II = 247
2 = T
8 = F
9 = S
14 = I
S = 39
6 = M
8 = MD
1 = ND
1 = F
10 = S
M = 131
50 = I
61 = M
Figure 2 The categorisation of cleft palate using the proposed
classification system compared with ICD-10.
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